[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370387-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370387-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","lrpprc-confers-enhanced-oxidative-phosphorylation-metabolism-in-triple-negative-breast-cancer-and-represents-a-therapeutic-target","LRPPRC confers enhanced oxidative phosphorylation metabolism in triple-negative breast cancer and represents a therapeutic target","","Triple-negative breast cancer (TNBC) is a highly malignant disease requiring precise therapeutic vulnerabilities. Oxidative phosphorylation (OXPHOS) is identified as a metabolic dependency, yet the mechanism driving enhanced OXPHOS in TNBC is unclear and existing targeting strategies cannot clearly separate tumor from normal cells. Using reanalyzed expression data and immunohistochemistry, the study tests LRPPRC’s role with in vitro and in vivo assays, RT-qPCR, immunoblotting, and Seahorse XF, and evaluates gossypol acetate (GAA) as an OXPHOS inhibitor.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/lrpprc-confers-enhanced-oxidative-phosphorylation-metabolism-in-triple-negative-breast-cancer-and-represents-a-therapeutic-target/370387/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/lrpprc-confers-enhanced-oxidative-phosphorylation-metabolism-in-triple-negative-breast-cancer-and-represents-a-therapeutic-target/370387.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What metabolic vulnerability does the paper focus on in triple-negative breast cancer?","Question",{"text":63,"@type":64},"It focuses on oxidative phosphorylation (OXPHOS) as a metabolic vulnerability in TNBC, where enhanced OXPHOS supports tumor aggressiveness.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does LRPPRC affect TNBC progression according to the study?",{"text":68,"@type":64},"LRPPRC is specifically overexpressed in TNBC; knocking it down suppresses TNBC proliferation, metastasis, and tumor formation.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does gossypol acetate (GAA) play in targeting OXPHOS?",{"text":72,"@type":64},"GAA inhibits OXPHOS metabolism by directly binding LRPPRC, promoting LRPPRC degradation and downregulating mitochondrial-encoded OXPHOS complex subunits, leading to reduced tumor growth in vivo and reduced malignant behaviors in vitro.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370387,1790217537,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Xue et al. Journal of Translational Medicine (2025) 23:372  \n[https://doi.org/10.1186/s12967-024-05946-6](https://doi.org/10.1186/s12967-024-05946-6)  \nJournal of Translational Medicine  \n RESEARCH Open Access  \nLRPPRC confers enhanced oxidative  \nphosphorylation metabolism in triple-negative breast cancer and represents a therapeutic target  \nQiqi Xue1,2,3†, Wenxi Wang1,2†, Jie Liu2, Dachi Wang2, Tianyu Zhang1,2, Tingting Shen2, Xiangsheng Liu2, Xiaojia Wang2,4, Xiying Shao4*, Wei Zhou2* and Xiaohong Fang1,2,3*  \nAbstract  \nBackground Triple-negative breast cancer (TNBC) is a highly malignant tumor that requires effective therapeutic targets and drugs. Oxidative phosphorylation (OXPHOS) is a metabolic vulnerability ofTNBC, but the molecular mechanism responsible for the enhanced OXPHOS remains unclear. The current strategies that target the electronic transfer function of OXPHOS cannot distinguish tumor cells from normal cells. Investigating the mechanism underlying OXPHOS regulation and developing corresponding therapy strategies forTNBC is of great significance. Methods Immunohistochemistry and sequencing data reanalysis were used to investigate LRPPRC expression inTNBC. In vitro and in vivo assays were applied to investigate the roles of LRPPRC inTNBC progression. RT-qPCR, immunoblotting, and Seahorse XF assay were used to examine LRPPRC’s functions in the expression of OXPHOS subunits and energy metabolism. In vitro and in vivo functional assays were used to test the therapeutic effect of gossypol acetate (GAA), a traditional gynecological drug, on LRPPRC suppression and OXPOHS inhibition.  \nResults LRPPRC was specifically overexpressed inTNBC. LRPPRC knockdown suppressed the proliferation, metastasis, and tumor formation ofTNBC cells. LRPPRC enhanced OXPHOS metabolism by increasing the expression ofOXPHOS complex subunits encoded by the mitochondrial genome. GAA inhibited OXPHOS metabolism by directly binding LRPPRC, causing LRPPRC degradation, and downregulating the expression ofOXPHOS complex subunits encoded by the mitochondrial genome. GAA administration suppressed TNBC cell proliferation, metastasis in vitro, and tumor formation in vivo.  \nConclusions This work demonstrated a new regulatory pathway ofTNBC to promote the expression of mitochondrial genes by upregulating the nuclear gene LRPPRC, resulting in increased OXPHOS. We also suggested  \n†Qiqi Xue and Wenxi Wang contributed equally to this work.  \n*Correspondence: Xiying Shao [shaoxy@zjcc.org.cn](shaoxy@zjcc.org.cn)[ ](shaoxy@zjcc.org.cn)Wei Zhou [zhouwei@him.cas.cn](zhouwei@him.cas.cn)[ ](zhouwei@him.cas.cn)Xiaohong Fang [xfang@iccas.ac.cn](xfang@iccas.ac.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nXue et al. Journal of Translational Medicine (2025) 23:372 Page 2 of 15  \na promising therapeut","cbCaiv5xVpZfNsRH","https://ap.wps.com/l/cbCaiv5xVpZfNsRH","pdf",10165187,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What metabolic vulnerability does the paper focus on in triple-negative breast cancer?\",\"answer\":\"It focuses on oxidative phosphorylation (OXPHOS) as a metabolic vulnerability in TNBC, where enhanced OXPHOS supports tumor aggressiveness.\"},{\"question\":\"How does LRPPRC affect TNBC progression according to the study?\",\"answer\":\"LRPPRC is specifically overexpressed in TNBC; knocking it down suppresses TNBC proliferation, metastasis, and tumor formation.\"},{\"question\":\"What role does gossypol acetate (GAA) play in targeting OXPHOS?\",\"answer\":\"GAA inhibits OXPHOS metabolism by directly binding LRPPRC, promoting LRPPRC degradation and downregulating mitochondrial-encoded OXPHOS complex subunits, leading to reduced tumor growth in vivo and reduced malignant behaviors in vitro.\"}]","LRPPRC confers enhanced oxidative phosphorylation metabolism in triple-negative breast cancer and represents a therapeutic target | PDF",1790188271,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1a3493df74b4e94f9afefa8f374de01.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1686ce1e09d0cefcb25a22341b062395.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c56b1412d69d59b65c5d04f6480e88fe.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1300b905502feae8d474dd025207ccab.webp",980,1301]